4MNA Stock Price and Chart — FWB:4MNA — TradingView

Overview

Financials News Ideas Discussions Forecast Seasonals

4MNA chart

4MNA upcoming earnings

Key stats

About Minerva Neurosciences, Inc

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.

Financials

Performance

Revenue to profit conversion

Debt level and coverage

Earnings

Next:—

Ideas

See all ideas

Technicals

Summarizing what the indicators are suggesting.

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

An aggregate view of professional's ratings.

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Seasonals

Displays a symbol's price movements over previous years to identify recurring trends.

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange MINERVA NEUROSC. DL-,0001 stocks are traded under the ticker 4MNA.

We've gathered analysts' opinions on MINERVA NEUROSC. DL-,0001 future price: according to them, 4MNA price has a max estimate of 4.58 EUR and a min estimate of 4.58 EUR. Watch 4MNA chart and read a more detailed MINERVA NEUROSC. DL-,0001 stock forecast: see what analysts think of MINERVA NEUROSC. DL-,0001 and suggest that you do with its stocks.

4MNA reached its all-time high on Aug 31, 2022 with the price of 14.46 EUR, and its all-time low was 1.19 EUR and was reached on Dec 29, 2022. View more price dynamics on 4MNA chart.
See other stocks reaching their highest and lowest prices.

Yes, you can track MINERVA NEUROSC. DL-,0001 financials in yearly and quarterly reports right on TradingView.

MINERVA NEUROSC. DL-,0001 is going to release the next earnings report on Mar 18, 2025. Keep track of upcoming events with our Earnings Calendar.

4MNA earnings for the last quarter are 2.67 EUR per share, whereas the estimation was −0.91 EUR resulting in a 394.06% surprise. The estimated earnings for the next quarter are −1.01 EUR per share. See more details about MINERVA NEUROSC. DL-,0001 earnings.

MINERVA NEUROSC. DL-,0001 revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.

4MNA net income for the last quarter is ‪20.22 M‬ EUR, while the quarter before that showed ‪−7.69 M‬ EUR of net income which accounts for 363.05% change. Track more MINERVA NEUROSC. DL-,0001 financial stats to get the full picture.

No, 4MNA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

As of Jan 14, 2025, the company has 9.00 employees. See our rating of the largest employees — is MINERVA NEUROSC. DL-,0001 on this list?

Like other stocks, 4MNA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MINERVA NEUROSC. DL-,0001 stock right from TradingView charts — choose your broker and connect to your account.